| Literature DB >> 27086021 |
Agnieszka Kamińska1, Evelin Witkowska2, Aneta Kowalska2, Anna Skoczyńska3, Iwona Gawryszewska3, Elżbieta Guziewicz4, Dymitr Snigurenko4, Jacek Waluk2,5.
Abstract
A highly efficient recognition unit based on surface-enhanced Raman spectroscopy (SERS) was developed as a promising, fast, and sensitive tool for detection of meningococcal meningitis, which is an extremely serious and often fatal disease of the nervous system (an inflammation of the lining around the brain and spinal cord). The results of this study confirmed that there were specific differences in SERS spectra between cerebrospinal fluid (CSF) samples infected by Neisseria meningitidis and the normal CSF, suggesting a potential role for neopterin in meningococcal meningitis detection and screening applications. To estimate the best performance of neopterin as a marker of bacterial infection, principal component analysis (PCA) was performed in a selected region (640-720 cm(-1)) where the most prominent SERS peak at 695 cm(-1) arising from neopterin was observed. The calculated specificity of 95 % and sensitivity of 98 % clearly indicate the effective diagnostic efficiency for differentiation between infected and control samples. Additionally, the limit of detection (LOD) of neopterin in CSF clinical samples was estimated. The level of neopterin was significantly higher in CSF samples infected by N. meningitidis (48 nmol/L), compared to the normal (control) group (4.3 nmol/L). Additionally, this work presents a new type of SERS-active nanostructure, based on polymer mats, that allows simultaneous filtration, immobilization, and enhancement of the Raman signal, enabling detection of spectra from single bacterial cells of N. meningitidis present in CSF samples. This provides a new possibility for fast and easy detection of bacteria in CSF and other clinical body fluids on a time scale of seconds. This method of detection produces consistent results faster and cheaper than traditional laboratory techniques, demonstrates the powerful potential of SERS for detection of disease, and shows the viability of future development in healthcare applications.Entities:
Keywords: Bacterial infections; Cerebrospinal fluid; Neisseria meningitidis; Neopterin; Surface-enhanced Raman spectroscopy (SERS)
Mesh:
Substances:
Year: 2016 PMID: 27086021 PMCID: PMC4875960 DOI: 10.1007/s00216-016-9535-7
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
Fig. 1Comparison of the SERS spectrum of the CSF samples infected by N. meningitidis (a) versus that of the normal (control) CSF samples (b). Samples of CSF were deposited onto the Si/ZnO/Au substrate and measured in situ. The inset shows the SERS spectrum of neopterin adsorbed onto the Si/ZnO/Au substrate from 35.0 nmol/L neopterin solution in a PBS buffer. The presented SERS spectra were averaged from ten measurements in different places of the SERS nanostructures
Fig. 2SEM images of the SERS nanostructures: (a) Au-coated Si/ZnO and (b) PLA polymer mat
Fig. 3(a) Plot of the first principal component PC1 (83 % of the total variance) versus the second principal component PC2 (9 % of the total variance) and (b) plot of the first principal component PC1 (83 % of the total variance) versus the third principal component PC3 (4 % of the total variance) for the normal group versus infected group. (c) Loadings plots of the first and second principal components PC1 and PC2, highlighting regions associated with large loadings
Fig. 4Scatter plots of the first two principal components PC1 (95 % of the total variance) and PC2 (2 % of the total variance) of the scores belonging to the control and N. meningitidis-infected CSF categories for the 640–720 cm−1 diagnostic range
Fig. 5(a) Scheme of the detection mechanism of neopterin. (b) The plot of the marker band intensity (695 cm−1) versus the neopterin concentration in CSF. The error bars indicate the standard deviations from ten averaged measurements
CSF neopterin concentration obtained using two methods, SERS and ELISA
| SERS (new method) | ELISA (reference method) | |
|---|---|---|
| Control CSF (nmol/L) | 3.8 ± 0.7 | 4.0 ± 1.3 |
| Infected CSF (nmol/L) (with | 30.0 ± 4.1 | 36.0 ± 5.2 |
Fig. 6The SERS spectrum of (a) CSF components trapped on a polymer mat-based SERS platform, (b) the remaining part of the filtrated solution deposited again on the Si/ZnO/Au substrate, and (c) the SERS spectrum of N. meningitidis multiplied before SERS experiment by cultivation in liquid LB (Lysogeny broth) growth medium and then deposited onto the Si/ZnO/Au substrate